The Effect of the Mixed Witepsol Base on the Drug Release from the Zonisamide Suppository.

Y. Mimaki, Kenya Kawakami, Chieko Imanaka, K. Suemaru, R. Taniguchi, Kazuhide Watanabe, H. Araki, Y. Gomita
{"title":"The Effect of the Mixed Witepsol Base on the Drug Release from the Zonisamide Suppository.","authors":"Y. Mimaki, Kenya Kawakami, Chieko Imanaka, K. Suemaru, R. Taniguchi, Kazuhide Watanabe, H. Araki, Y. Gomita","doi":"10.5649/JJPHCS1975.26.171","DOIUrl":null,"url":null,"abstract":"The influences of both the mixing ratios of Witepsol as a lipophilic base and the temperature on the drug release from the zonisamide suppositories was investigated. Mixed types of zonisamide suppositories consisting of Witepsol H-15 (H) and Witepsol S-55 (S) as a lipophilic base were prepared and the release of zonisamide from a suppository was determined using the dissolution apparatus in Paddle method of JPX III. The release rate of zonisamide from the Witepsol (H: S=4: 1) suppository and Witepsol (H: S=3: 1) suppository at 4 hours after start of the release test were 66.6% and 56.5%, respectively. The former was significantly higher (p<0.05) than that of the latter. The release volume and mean dissolution time (MDT) of zonisamide from a suppository increased and decreased, respectively, according to the high mixing ratio of Witepsol H 15.The effect of low temperature (32 and 34°C) on drug release from the zonisamide suppositories was also studied using artificial membranes. The drug release properties were changed according to the mixing ratios of the two lipophilic bases and the temperature of the fluid tested. At a low temperature, the amount of released zonisamide correlated with the ratio of Witepsol S 55 in the suppository. However, the amount of the drug released from the zonisamide suppositories decreased at temperatures lower than normal body temperature. These results indicate that the ratio of Witepsol H 15 and Witepsol S 55 in suppositories was important while the temperature also influence drug absorption from the rectum with zonisamide suppositories.","PeriodicalId":14621,"journal":{"name":"Japanese Journal of Hospital Pharmacy","volume":"147 1","pages":"171-176"},"PeriodicalIF":0.0000,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5649/JJPHCS1975.26.171","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

The influences of both the mixing ratios of Witepsol as a lipophilic base and the temperature on the drug release from the zonisamide suppositories was investigated. Mixed types of zonisamide suppositories consisting of Witepsol H-15 (H) and Witepsol S-55 (S) as a lipophilic base were prepared and the release of zonisamide from a suppository was determined using the dissolution apparatus in Paddle method of JPX III. The release rate of zonisamide from the Witepsol (H: S=4: 1) suppository and Witepsol (H: S=3: 1) suppository at 4 hours after start of the release test were 66.6% and 56.5%, respectively. The former was significantly higher (p<0.05) than that of the latter. The release volume and mean dissolution time (MDT) of zonisamide from a suppository increased and decreased, respectively, according to the high mixing ratio of Witepsol H 15.The effect of low temperature (32 and 34°C) on drug release from the zonisamide suppositories was also studied using artificial membranes. The drug release properties were changed according to the mixing ratios of the two lipophilic bases and the temperature of the fluid tested. At a low temperature, the amount of released zonisamide correlated with the ratio of Witepsol S 55 in the suppository. However, the amount of the drug released from the zonisamide suppositories decreased at temperatures lower than normal body temperature. These results indicate that the ratio of Witepsol H 15 and Witepsol S 55 in suppositories was important while the temperature also influence drug absorption from the rectum with zonisamide suppositories.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
复方威普索尔对唑尼沙胺栓释药的影响。
考察了威普索尔作为亲脂碱的混合配比和温度对佐尼沙胺栓释药的影响。采用JPX III的Paddle法,制备了以Witepsol H-15 (H)和Witepsol S-55 (S)为亲脂碱的混合型唑尼沙胺栓剂,并用溶出仪测定了栓体中唑尼沙胺的释放度。释放试验开始后4小时,唑尼沙胺在威普索尔(H: S= 4:1)栓剂和威普索尔(H: S= 3:1)栓剂中的释放率分别为66.6%和56.5%。前者显著高于后者(p<0.05)。随着Witepsol h15的混合比例增大,唑尼沙胺的释放量增大,平均溶出时间(MDT)减小。低温(32℃和34℃)对佐尼沙胺栓剂药物释放的影响也采用人工膜进行了研究。根据两种亲脂碱的混合比例和所测液体的温度改变药物的释放特性。在低温下,佐尼沙胺的释放量与威普索尔s55在栓剂中的比例相关。然而,从唑尼沙胺栓剂释放的药物量在温度低于正常体温时减少。这些结果表明,栓剂中威普索尔h15和s55的比例是重要的,而温度也影响佐尼沙胺栓从直肠吸收药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Assessment and Analysis of the Assessment Criteria for Meta-Analysis Articles:─ Management of Diabetes Pharmacotherapy Based on Meta-Analysis Articles ─ ベネコートBMI-40とBMI-60との苦味マスキング効果の比較 「創薬ボランティアのしおり」,「被験者管理票」の利用と治験コーディネーター業務 Hemodializability of Pimobendan and Its Active Metabolite, UD-CG 212, in Patients with Congestive Heart Failure Undergoing Hemodialysis An Investigation into the Current Management for Patients with Long-Term Withdrawal Periods from Drugs
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1